» Articles » PMID: 15490270

The Serum Level of Bone-specific Alkaline Phosphatase Activity is Associated with Aortic Calcification in Osteoporosis Patients

Overview
Specialty Endocrinology
Date 2004 Oct 19
PMID 15490270
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

It has been suggested that there are several possible linkages between vascular calcification and osteoporosis. In addition, the processes of vascular calcification may have a common etiology with bone formation. Thus, we hypothesized that the serum levels of bone metabolic markers would be different between osteoporosis patients with and without vascular calcification. In this study, we showed that the serum level of bone-specific alkaline phosphatase activity in osteoporosis patients with abdominal aortic calcification had a higher value than in those without the calcification. On the other hand, there were no significant differences in the urine levels of type I collagen cross-linked N-telopeptides (a bone resorption marker), or in the serum levels of intact osteocalcin, Ca, and P. Bone-specific alkaline phosphatase is the most important marker for osteoblast differentiation; furthermore, the serum level of its activity may reflect the process of calcification of the aorta in osteoporosis patients.

Citing Articles

Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19.

Kazemi-Sufi S, Alipour S, Rabieepour M, Roshan-Milani S, Naderi R BMC Infect Dis. 2024; 24(1):1047.

PMID: 39333916 PMC: 11428542. DOI: 10.1186/s12879-024-09941-6.


Interpretable Deep-Learning Approaches for Osteoporosis Risk Screening and Individualized Feature Analysis Using Large Population-Based Data: Model Development and Performance Evaluation.

Suh B, Yu H, Kim H, Lee S, Kong S, Kim J J Med Internet Res. 2022; 25:e40179.

PMID: 36482780 PMC: 9883743. DOI: 10.2196/40179.


Bone Specific Alkaline Phosphatase and Serum Calcification Propensity Are Not Influenced by Etelcalcetide vs. Alfacalcidol Treatment, and Only Bone Specific Alkaline Phosphatase Is Correlated With Fibroblast Growth Factor 23: Sub-Analysis Results of....

Dorr K, Hodlmoser S, Kammer M, Reindl-Schwaighofer R, Lorenz M, Reiskopf B Front Med (Lausanne). 2022; 9:948177.

PMID: 35872799 PMC: 9299083. DOI: 10.3389/fmed.2022.948177.


Alkaline Phosphatase: An Old Friend as Treatment Target for Cardiovascular and Mineral Bone Disorders in Chronic Kidney Disease.

Haarhaus M, Cianciolo G, Barbuto S, La Manna G, Gasperoni L, Tripepi G Nutrients. 2022; 14(10).

PMID: 35631265 PMC: 9144546. DOI: 10.3390/nu14102124.


Ascending Aortic Calcification as a Potential Predictor for Low Bone Mineral Density: A Pilot Study.

Bekki H, Arizono T, Suzuki Y, Inokuchi A, Hamada T, Imamura R J Osteoporos. 2021; 2021:5526359.

PMID: 34136118 PMC: 8177974. DOI: 10.1155/2021/5526359.